SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001013594-18-000585
Filing Date
2018-10-15
Accepted
2018-10-15 16:31:02
Documents
2

Document Format Files

Seq Description Document Type Size
1 OCTOBER 10, 2018 eiger13g-101018.htm SC 13G 75503
2 JOINT FILING AGREEMENT eigerex991-101018.htm EX-99.1 4557
  Complete submission text file 0001013594-18-000585.txt   81513
Mailing Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019 (212) 554-2379
683 Capital Management, LLC (Filed by) CIK: 0001404574 (see all company filings)

IRS No.: 205100992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 350 CAMBRIDGE AVENUE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVENUE SUITE 350 PALO ALTO CA 94306 650-272-6138
EIGER BIOPHARMACEUTICALS INC (Subject) CIK: 0001454815 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90678 | Film No.: 181122532